The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15261, USA.
Nat Commun. 2022 Feb 25;13(1):1054. doi: 10.1038/s41467-022-28586-0.
The formylpeptide receptors (FPRs) mediate pattern recognition of formylated peptides derived from invading pathogens or mitochondria from dead host cells. They can also sense other structurally distinct native peptides and even lipid mediators to either promote or resolve inflammation. Pharmacological targeting of FPRs represents a novel therapeutic approach in treating inflammatory diseases. However, the molecular mechanisms underlying FPR ligand recognition are elusive. We report cryo-EM structures of G-coupled FPR1 and FPR2 bound to a formylpeptide and G-coupled FPR2 bound to two synthetic peptide and small-molecule agonists. Together with mutagenesis data, our structures reveal the molecular mechanism of formylpeptide recognition by FPRs and structural variations of FPR1 and FPR2 leading to their different ligand preferences. Structural analysis also suggests that diverse FPR agonists sample a conserved activation chamber at the bottom of ligand-binding pockets to activate FPRs. Our results provide a basis for rational drug design on FPRs.
甲酰肽受体(FPRs)介导对来自入侵病原体或宿主细胞死亡线粒体的甲酰肽的模式识别。它们还可以感知其他结构不同的天然肽,甚至脂质介质,以促进或解决炎症。针对 FPR 的药理学靶向是治疗炎症性疾病的一种新的治疗方法。然而,FPR 配体识别的分子机制尚不清楚。我们报告了与甲酰肽结合的 G 偶联 FPR1 和 FPR2 的冷冻电镜结构,以及与两种合成肽和小分子激动剂结合的 G 偶联 FPR2。结合突变数据,我们的结构揭示了 FPR 识别甲酰肽的分子机制,以及 FPR1 和 FPR2 的结构变化导致它们对不同配体的偏好。结构分析还表明,不同的 FPR 激动剂在配体结合口袋底部的保守激活腔内取样,以激活 FPR。我们的研究结果为 FPR 的合理药物设计提供了基础。